Skip to main content
. 2018 Aug 1;9(4):350–356. doi: 10.3892/br.2018.1137

Table III.

OR (95% CI) of genotypic frequency of SNPs at VDR and TNFSF11 in osteoporosis patients and control subjects.

SNP Genotype OR (95% CI) P-value
VDR
  rs731236 CC 2.54 (0.18–7.26) 0.41
CT 0.47 (0.16–1.36) 0.13
TT 1.67 (0.67–4.48) 0.25
  rs15444410 AA 0.31 (0.01–2.98) 0.26
GA 0.95 (0.46–1.92) 0.89
GG 1.20 (0.60–2.38) 0.58
  rs2228570 TT 2.30 (1.14–4.69) 0.01
CT 0.63 (0.36–1.09) 0.08
CC 0.93 (0.51–1.69) 0.80
TNFSF11
  rs9533155 GG 0.74 (0.31–1.75) 0.46
CG 1.29 (0.75–2.23) 0.33
CC 0.87 (0.50–1.53) 0.61
  rs9533156 CC 0.75 (0.33–1.67) 0.44
CT 1.31 (0.76–2.27) 0.30
TT 0.85 (0.49–1.54) 0.60
  rs9525641 CC 0.96 (0.41–2.20) 0.91
CT 1.24 (0.72–2.15) 0.41
TT 0.80 (0.45–1.43) 0.43

OR, odds ratio; CI, confidence interval; SNP, single nucleotide polymorphism; VDR, vitamin D receptor; TNFSF11, tumor necrosis factor superfamily member 11.